Gökhan Erdem

815 total citations
30 papers, 590 citations indexed

About

Gökhan Erdem is a scholar working on Surgery, Epidemiology and Pharmacology. According to data from OpenAlex, Gökhan Erdem has authored 30 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Epidemiology and 5 papers in Pharmacology. Recurrent topics in Gökhan Erdem's work include Adipokines, Inflammation, and Metabolic Diseases (7 papers), Apelin-related biomedical research (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Gökhan Erdem is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (7 papers), Apelin-related biomedical research (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Gökhan Erdem collaborates with scholars based in Türkiye, Cambodia and Antigua and Barbuda. Gökhan Erdem's co-authors include Alper Sönmez, Serkan Tapan, Teoman Doğru, İlker Taşçı, Halil Genç, Mahmut İlker Yılmaz, Selim Kılıç, Sezin Bingöl, Necati Bingöl and Ergün Bozoğlu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Atherosclerosis and Journal of Hypertension.

In The Last Decade

Gökhan Erdem

27 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gökhan Erdem Türkiye 12 246 204 187 150 111 30 590
James Simpkin United Kingdom 5 208 0.8× 200 1.0× 134 0.7× 118 0.8× 31 0.3× 6 633
Gökhan Üçkaya Türkiye 17 93 0.4× 164 0.8× 117 0.6× 89 0.6× 228 2.1× 38 694
Zuzana Kováčová Czechia 14 135 0.5× 140 0.7× 381 2.0× 208 1.4× 66 0.6× 19 797
Miriam Dreßler Germany 15 106 0.4× 142 0.7× 314 1.7× 136 0.9× 30 0.3× 28 790
Annis Marney United States 10 53 0.2× 205 1.0× 54 0.3× 107 0.7× 292 2.6× 20 887
K Kumano Japan 9 501 2.0× 443 2.2× 72 0.4× 126 0.8× 136 1.2× 23 711
Sarah L. Prior United Kingdom 18 50 0.2× 204 1.0× 120 0.6× 84 0.6× 121 1.1× 35 679
Liad Hinden Israel 13 220 0.9× 176 0.9× 55 0.3× 21 0.1× 161 1.5× 25 568
Sezin Bingöl Türkiye 9 68 0.3× 63 0.3× 173 0.9× 70 0.5× 87 0.8× 11 392
Raphaela Schlich Germany 8 32 0.1× 112 0.5× 188 1.0× 166 1.1× 134 1.2× 8 635

Countries citing papers authored by Gökhan Erdem

Since Specialization
Citations

This map shows the geographic impact of Gökhan Erdem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gökhan Erdem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gökhan Erdem more than expected).

Fields of papers citing papers by Gökhan Erdem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gökhan Erdem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gökhan Erdem. The network helps show where Gökhan Erdem may publish in the future.

Co-authorship network of co-authors of Gökhan Erdem

This figure shows the co-authorship network connecting the top 25 collaborators of Gökhan Erdem. A scholar is included among the top collaborators of Gökhan Erdem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gökhan Erdem. Gökhan Erdem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Erdem, Gökhan. (2021). Artificial intelligence-powered ultrasound guided regional nerve block in 3 patients: case report. Ağrı - The Journal of The Turkish Society of Algology. 35(3). 167–171. 3 indexed citations
3.
Salihoğlu, Ayşe, Tuğrul Elverdi, Ìhsan Karadoǧan, et al.. (2014). Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey. Annals of Hematology. 94(3). 415–420. 22 indexed citations
4.
Taşçı, İlker, et al.. (2013). A Case with POEMS Syndrome Presenting with Loss of Vision and Skeletal Muscle Strength. 1 indexed citations
5.
Genç, Halil, Teoman Doğru, Serkan Tapan, et al.. (2011). Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: The impact of metabolic syndrome. Clinical Biochemistry. 45(1-2). 92–95. 14 indexed citations
6.
Sönmez, Alper, Gürkan Çelebi, Gökhan Erdem, et al.. (2010). Plasma Apelin and ADMA Levels in Patients with Essential Hypertension. Clinical and Experimental Hypertension. 32(3). 179–183. 79 indexed citations
7.
Sönmez, Alper, Gürkan Çelebi, Gökhan Erdem, et al.. (2010). PLASMA APELIN AND ADMA LEVELS IN PATIENTS WITH ESSENTIAL HYPERTENSION: PP.12.451. Journal of Hypertension. 28. e186–e186.
8.
Sönmez, Alper, Cem Haymana, Serkan Tapan, et al.. (2010). Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus. Endocrine. 37(3). 455–459. 29 indexed citations
9.
Kutlu, Mustafa, Alper Sönmez, Halil Genç, et al.. (2009). Relationship between hemoglobin and CD40 ligand in prediabetes. Clinical and investigative medicine. 32(6). E244–E250. 16 indexed citations
10.
Erdem, Gökhan, Halil Genç, Serkan Tapan, et al.. (2008). Circulating von Willebrand Factor Levels in Patients with Prediabetes. Turkiye Klinikleri Tip Bilimleri Dergisi. 28(6). 822–827. 1 indexed citations
11.
Taşçı, İlker, Gökhan Erdem, Teoman Doğru, et al.. (2008). Ewing’s sarcoma of the fibula presenting with venous thrombosis. Clinical & Translational Oncology. 10(12). 847–849. 3 indexed citations
12.
Erdem, Gökhan, et al.. (2008). Low Plasma Apelin Levels in Newly Diagnosed Type 2 Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes. 116(5). 289–292. 102 indexed citations
13.
Erdem, Gökhan, Teoman Doğru, İlker Taşçı, et al.. (2008). The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 82(2). 214–218. 24 indexed citations
14.
Taşçı, İlker, Gökhan Erdem, Serkan Tapan, et al.. (2008). LDL-cholesterol lowering increases plasma apelin in isolated hypercholesterolemia. Atherosclerosis. 204(1). 222–228. 40 indexed citations
15.
Doğru, Teoman, Halil Genç, İlker Taşçı, et al.. (2007). Platelet Aggregation is not Enhanced in Patients with Prediabetes. Upsala Journal of Medical Sciences. 112(3). 338–346. 4 indexed citations
16.
Naharcı, Mehmet İlkin, Gökhan Erdem, Mahmut İlker Yılmaz, et al.. (2007). Plasma Apelin is Lower in Patients with Elevated LDL-Cholesterol. Experimental and Clinical Endocrinology & Diabetes. 115(7). 428–432. 48 indexed citations
17.
Sönmez, Alper, Halil Genç, Mahmut Gök, et al.. (2006). The plasma levels of soluble P-selectin in subjects with prediabetes. International Journal of Clinical Practice. 60(9). 1048–1052. 11 indexed citations
18.
Doğru, Teoman, Alper Sönmez, İlker Taşçı, et al.. (2006). Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Research and Clinical Practice. 76(1). 24–29. 156 indexed citations
19.
Taşçı, İlker, Teoman Doğru, Alper Sönmez, et al.. (2006). Soluble CD40 Ligand Levels in Otherwise Healthy Subjects With Impaired Fasting Glucose. Mediators of Inflammation. 2006(1). 32508–32508. 4 indexed citations
20.
Işık, Ahmet Turan, Mehmet Refik Mas, Levent Yamanel, et al.. (2006). The role of allopurinol in experimental acute necrotizing pancreatitis.. PubMed. 124(6). 709–14. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Simpkin Breakdown of academic impact, for papers by Gökhan Üçkaya Breakdown of academic impact, for papers by Zuzana Kováčová Breakdown of academic impact, for papers by Miriam Dreßler Breakdown of academic impact, for papers by Annis Marney Breakdown of academic impact, for papers by K Kumano Breakdown of academic impact, for papers by Sarah L. Prior Breakdown of academic impact, for papers by Liad Hinden Breakdown of academic impact, for papers by Sezin Bingöl Breakdown of academic impact, for papers by Raphaela Schlich
Rankless by CCL
2026